Checkerspot Stock

checkerspot.comIndustrial / MaterialsFounded: 2016Funding to Date: $94.72MM

Checkerspot is a San Francisco-based biotechnology company that seeks to develop high-performance alternatives to everyday consumer products. The company’s goal is to enable manufacturers to choose materials that use bio-based alternatives to petroleum. This is accomplished through the design of performance materials at a molecular level that optimize microbes to biomanufacture structural oils produced in nature.

Register To Buy and Sell Shares

For more details on financing and valuation for Checkerspot, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Checkerspot’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Checkerspot.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Checkerspot investors also invested in these private companies

Team

Management Team

Charles Dimmler
Co-Founder & Chief Executive Officer
Nazz Kurth
Chief Operating Officer
Scott Franklin Ph.D
Scientific Co-Founder & Chief Scientific Officer
Susan Wong
Head of Finance and Operations

Board Members

Brian Rose
Viking Global Investors
Cain McClary MD
KdT Ventures
James Kim
Builders VC
Julia Moore
Breakout Ventures

Frequently Asked Questions About Checkerspot’s Stock

plusminus
Can you buy Checkerspot’s stock?
Checkerspot is not publicly traded on NYSE or NASDAQ in the U.S. To buy Checkerspot’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Checkerspot’s stock?
Yes, you can sell stock of a private company like Checkerspot. Forge can help you sell your Checkerspot stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Checkerspot’s stock price?
Checkerspot is a privately held company and therefore does not have a public stock price. However, you may access Checkerspot’s private market stock price with Forge Data.
plusminus
What is Checkerspot’s stock ticker symbol?
Checkerspot does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Checkerspot Closes $55 Million Series C to Bring the Bioeconomy to Your Doorstep
Checkerspot, Inc., a biotechnology company with an award-winning design and innovation lab, announced the close of a $55 million Series C financing led by ArrowMark Partners, with participation from Cox Enterprises and other new and existing investors.
Checkerspot releases algae-based plastic prototype kit for designers
California materials company Checkerspot has launched a casting kit named Pollinator Kit that allows designers to experiment with making components from algae-based plastics.
Updated on: Apr 18, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.